Carinase 15 MIU Injection
Marketer
Health Biotech Limited
Salt Composition
Urokinase (15Million IU)
Overview Carinase 15 MIU Injection
Thrombolytic agent Carinase 15 MIU Injection dissolves dangerous blood clots obstructing blood vessels. It's indicated for post-heart attack patients and those experiencing pulmonary embolism or stroke. Administration requires strict medical oversight; dosage and treatment length are determined individually by your physician, who will monitor your recovery closely. Potential side effects include nausea, vomiting, injection site hemorrhage, allergic reactions, and hypotension, along with a heightened bleeding risk. Your doctor will discuss potential benefits and risks prior to treatment. Continue all prescribed medications as directed, even after receiving this injection. Caution is advised for individuals with bleeding disorders, hepatic or renal impairment, pregnancy, or breastfeeding. Always disclose all current medications to your physician.
Primary Ingredients of Carinase 15 MIU Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Carinase 15 MIU Injection
Myocardial infarction/Pulmonary thromboembolism
Major Benefits of Carinase 15 MIU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Carinase 15 MIU Injection:
- Allergic reaction
- Nausea
- Vomiting
- Injection site bleeding
- Decreased blood pressure
How to use Carinase 15 MIU Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Carinase 15 MIU Injection works:
Carinase 15 MIU Injection clears dangerous blood clots from blood vessels, thus reinstating blood circulation to compromised tissue. This action averts tissue necrosis and enhances patient recovery.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Carinase 15 MIU Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Carinase 15 MIU is generally deemed safe for use in pregnancy. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; however, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Carinase 15 MIU Injection while breastfeeding appears to pose minimal risk. Available human data indicate negligible danger to the infant.
DrivingNOT RELEVANT
Carinase 15 MIU Injection is administered solely within a hospital setting.
KidneySAFE IF PRESCRIBED
Carinase 15 MIU Injection appears safe for individuals with kidney impairment; current evidence indicates dose modification may be unnecessary. However, physician consultation is advised. The injection is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Individuals with hepatic impairment should use Carinase 15 MIU Injection cautiously. Dosage modification of Carinase 15 MIU Injection may be necessary. Physician consultation is advised.
What if you forget to take Carinase 15 MIU Injection :
Should you forget a Carinase 15 MIU Injection, seek your physician's advice.
Facts to Know About Carinase 15 MIU Injection
| Label | Value |
|---|---|
| Chemical Classification | Amino acid and peptide analogs |
| Developing Habits | No. |
| Type of Therapy | Heart |
| Action Class | Early Thrombolytic Agents |
3,018 People bought this recently